D. B. Renner
Intranasal deferoxamine engages multiple pathways to decrease memory loss in the APP/PS1 model of amyloid accumulation
Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinsons disease
Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice
Experimental Brain Research.
Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice
Drug delivery and translational research.
Intranasal delivery of insulin via the olfactory nerve pathway
Journal of Pharmacy and Pharmacology.
Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway
Intranasally administered deferoxamine induces neuroprotection in a 6-OHDA model of Parkinson's disease [poster]
Intranasal deferoxamine improves spatial memory through a non-amyloid mechanism in APP/PS1 mice [presentation]
Proteomic approach to the study of neuroprotection following intranasal deferoxamine [presentation]
Map of science